O Donnell Financial Services, LLC 9 Meters Biopharma, Inc. Transaction History

O Donnell Financial Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$0.21 - $0.32 $357 - $544	1,700 Added 0.19%	878,171 $189,000
Q2 2022 Jul 27, 2022	BUY	$0.26 - $0.64 $5,744 - $14,141	22,096 Added 2.59%	876,471 $229,000
Q1 2022 May 04, 2022	BUY	$0.52 - $1.0 $908 - $1,747	1,747 Added 0.2%	854,375 $512,000
Q4 2021 Feb 02, 2022	BUY	$0.85 - $1.33 $10,115 - $15,828	11,901 Added 1.42%	852,628 $629,000
Q3 2021 Oct 29, 2021	BUY	$1.03 - $1.41 $865,948 - $1.19 Million	840,727 New	840,727 $1.09 Million

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of O Donnell Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on O Donnell Financial Services, LLC with notifications on news.